Work

Phase II, open label, multi-dose study of 89-Zr-Df-IAB22M2C (CD8 Immuno-PET Tracer): technical handling and injection instructions for optimal tracer administration.

Year: 2021

Type: article

Source: Journal of Nuclear Medicine

Authors: Kaylee Allred, Quinten Sanders, Monica Prince, Ron Korn, Ian A. Wilson, William Le, Avital Weiss, Amanda Abbott, David R. Hays

Institutions: Central Arkansas Radiation Therapy Institute, ImaginAb (United States), Society of Nuclear Medicine and Molecular Imaging

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3183117258

FWCI:

Cites:

Cited by:

Related to: 20